drugset / Trial / NCT00609102
Antioxidant Treatment of Type 2 Diabetes
Phase 0
Completed
44 enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
RandomizedSingle-groupSingle-blindTreatment
Summary
This study examines whether an antioxidant taken orally will improve glucose tolerance and insulin secretion in type 2 diabetic subjects.
Timeline
- Start
- 2008-07
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | N-acetylcysteine | Small molecule | 450 mg | Oral |